HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

High injection pressure during intralesional injection of corticosteroids into capillary hemangiomas.

AbstractBACKGROUND:
Intralesional injection of corticosteroids is an effective treatment for tumors of the head and neck. Complications are rare but include permanent loss of vision. We designed a study to investigate the mechanism for this complication.
METHODS:
Three fellowship-trained pediatric ophthalmologists participated in the study in a nonmasked fashion. Four patients received 5 separate treatment sessions of an intralesional injection of a 50-50 mixture of triamcinolone diacetate (40 mg/mL) and betamethasone sodium phosphate and betamethasone acetate (6 mg/mL) into capillary hemangiomas. Injection pressure was obtained in real time using a cannula designed for this purpose. Maximum pressure, mean pressure, and volume of corticosteroid were measured from each injection.
RESULTS:
A total of 71 injections (range, 8-33 injections per patient) was performed. The total volume of corticosteroid ranged from 0.9 to 2.1 mL. In 63 of 71 injections, the maximum pressure exceeded 100 mm Hg (range, 18.65-842.18 mm Hg). Each surgeon produced injection pressures greater than the systemic arterial pressures of each patient.
CONCLUSIONS:
Injection pressures exceeding the systemic arterial pressures routinely occur during intralesional injections of corticosteroids into capillary hemangiomas. Experienced surgeons participating in a nonmasked protocol were unable to prevent high injection pressures of corticosteroid. A sufficient volume of corticosteroid injected at high injection pressure would account for the embolization of corticosteroid particles into the ocular circulation from retrograde arterial flow. We recommend limiting the volume of corticosteroid and performing indirect ophthalmoscopy on all patients receiving injections of long-acting corticosteroids into the orbit and periorbital soft tissue.
AuthorsJ E Egbert, S Paul, W K Engel, C G Summers
JournalArchives of ophthalmology (Chicago, Ill. : 1960) (Arch Ophthalmol) Vol. 119 Issue 5 Pg. 677-83 (May 2001) ISSN: 0003-9950 [Print] United States
PMID11346395 (Publication Type: Case Reports, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Glucocorticoids
  • Triamcinolone
  • betamethasone acetate phosphate
  • betamethasone sodium phosphate
  • Betamethasone
  • triamcinolone diacetate
Topics
  • Betamethasone (administration & dosage, adverse effects, analogs & derivatives)
  • Blood Pressure
  • Embolism (etiology)
  • Eye (blood supply)
  • Eyelid Neoplasms (drug therapy, pathology)
  • Female
  • Glucocorticoids (administration & dosage, adverse effects)
  • Hemangioma, Capillary (drug therapy, pathology)
  • Humans
  • Infant
  • Injections, Intralesional
  • Male
  • Orbital Neoplasms (drug therapy, pathology)
  • Postoperative Complications
  • Pressure (adverse effects)
  • Triamcinolone (administration & dosage, adverse effects, analogs & derivatives)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: